PharmaShots | Incisive News in 3 Shots

Subscribe Now

Tigen

Tigen Exercises its Option to License Neoantigen-specific Tumor Infiltrating Lymphocytes for Solid Tumor

Tigen Exercises its Option to License Neoantigen-specific Tumor Infiltrating Lymphocytes for Solid Tumor

October 18, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us